InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Huff James Warren. Officer active across 1 company, notably Reata Pharmaceuticals INC. Aggregated, 4 reports have been logged. Activity tracked since 3 January 2023. The latest transaction was disclosed on 6 July 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Huff James Warren has 4 filings in total. The 4 sampled filings run from 2023-01-04 to 2023-09-26 and all relate to Reata Pharmaceuticals INC, where he is Chief Executive Officer. The total buy and sell amounts in these sampled filings are 0 EUR for buys and 0 EUR for sells, with the modal transaction nature listed as Attribution.